COTE D'IVOIRE

Cote d’Ivoire began working with PIVI in 2018, and in addition to having a vaccine policy cooperative agreement with the Centers for Disease Control and Prevention. Cote d’Ivoire conducted a Knowledge, Attitudes and Practices (KAP) survey to assess the acceptability of vaccine among key risk groups. This information has been used to forecast uptake and vaccine needs, and to craft targeted messages to address hesitancy and increase vaccine use. In 2019 they completed a small pilot vaccination campaign focused on healthcare workers and diabetics. The pilot showed broad acceptance of the vaccine, and data gathered encouraged the Ministry of Health to continue to strengthen and grow the program.

They were able to expand vaccination in 2020 to vaccinate 15,000 in health workers in the regions of Abidjan, Cavally, Gbêké, Grand Pont, Indenie Djuablin, Poro, Sud Comoe, and Tonkpi.

Cote d’Ivoire has also completed a National Immunization Technical Assistance Group (NITAG) flu working group training, and their high level NITAG functioning has positioned them as a leader in African regional NITAG groups. The draft policy recommendation produced after the workshop was presented to the CNEIV, Cote d’Ivoire’s NITAG in order to support policy decisions.